Click a link below to view the mailing archive as if it had been sent to you.
| 2014-10-31 12:15 | | Lawmaker Plans a Bill to Force Pharma to Disclose Compassionate Use Info and more... |
| 2014-10-31 00:15 | | Feeling Dissed, Amgen Sues After Sandoz Abandons the BPCIA Patent Dance Procedures for NEUPOGEN Biosimilar; Alleges Unfa... and more... |
| 2014-10-30 12:15 | | Dendreon And CMS Under SEC Scrutiny Over Insider Trading and more... |
| 2014-10-30 00:15 | | Cubist Pharmaceuticals names chief executive and more... |
| 2014-10-29 12:15 | | MannKind: What To Expect From Earnings and more... |
| 2014-10-29 00:15 | | Orphan drug pricing for non-orphan meds? Express Scripts is looking at you, Gilead and more... |
| 2014-10-28 12:15 | | [video]Amgen CEO: We're not splitting up and more... |
| 2014-10-28 00:15 | | Amgen profit tops Wall Street expectations; raises 2014 outlook and more... |
| 2014-10-27 12:15 | | Breakthrough Pathway: Lone Bright Spot Among the Macro Trends for Medical Devices? and more... |
| 2014-10-26 12:15 | | Reckitt Benckiser to detail spin-off plan next month and more... |
| 2014-10-26 00:15 | | 3D printing may make individualized medicine more affordable |
| 2014-10-25 12:15 | | Hikma Pharmaceuticals receives warning over Portugal facility and more... |
| 2014-10-25 00:15 | | Biotech Offerings Fuel Health Care IPO Dominance and more... |
| 2014-10-24 12:15 | | Mead Johnson Rises On Earnings Beat and more... |
| 2014-10-24 00:15 | | In biotech's boardrooms, there are 10 men for every one woman, report says and more... |
| 2014-10-23 12:15 | | GSK restructures, as respiratory disappoints and more... |
| 2014-10-23 00:15 | | The Mylan-Abbott Inversion Deal is Still onâ?Ç?ª but With Some Changes and more... |
| 2014-10-22 12:15 | | Roche blueprints a $1.8B R&D complex for pRED and more... |
| 2014-10-22 00:15 | | Biogen Leads 5 Top Biotech Stocks As Earnings Loom and more... |
| 2014-10-21 12:15 | | AbbVie's $55B deal for Shire is officially dead. Now what? and more... |
| 2014-10-21 00:15 | | Allergan files rebuttal to Valeant earnings and more... |
| 2014-10-20 12:15 | | Genervon ALS drug shows encouraging results and more... |
| 2014-10-20 00:15 | | This Drug Could Outsell Medical Marijuana and more... |
| 2014-10-19 12:15 | | Latest Actos Bladder Cancer Trial Starts in West Virginia and more... |
| 2014-10-18 12:15 | | Better Late Than Never: CMS Improves The Doctor Payment Website and more... |
| 2014-10-18 00:15 | | Will ObamaCare Help McKesson, Other Drug Companies? and more... |
| 2014-10-17 12:15 | | Horizon acquires U.S. rights to osteoarthritis drug and more... |
| 2014-10-17 00:15 | | FDA Announces Major Agency Reorganization, With Focus on Drug Quality and more... |
| 2014-10-16 12:15 | | Brainstorm CEO Offers Investors a Frank Outlook for ALS Therapy and more... |
| 2014-10-16 00:15 | | Roche, Boehringer Drugs Wins Approval for Lung Disease and more... |
| 2014-10-15 12:15 | | Selecta banks $20M for trial work, inks a pact with Sanofi on diabetes and more... |
| 2014-10-15 00:15 | | Will an FDA Policy Shift on Fixed-Dose Drug Approvals Anger Pharma? and more... |
| 2014-10-14 12:15 | | GW Pharma's cannabis-based drug comes up short in ulcerative colitis and more... |
| 2014-10-14 00:15 | | Sarepta Drug Could Benefit From Duchenne Muscular Dystrophy Patient Study and more... |
| 2014-10-13 12:15 | | Bristol-Myers, Otsuka ask judge to nix Abilify kickback suit and more... |
| 2014-10-12 12:15 | | Ebola May Spike Demand for This Surprising IPO Stock and more... |
| 2014-10-11 12:15 | | Texas takes exception to AstraZeneca's marketing of antipsychotic and more... |
| 2014-10-11 00:15 | | Gilead Wins U.S. Approval for Hepatitis C Combo Pill and more... |
| 2014-10-10 12:15 | | Kimberly-Clark to spin out Halyard Health Oct. 31 and more... |
| 2014-10-10 00:15 | | Sanofi bird flu vax prompts immune response in PhII--but only with Novartis adjuvant and more... |
| 2014-10-09 12:15 | | Boston Therapeutics Inc reports topline U.S.-based phase IIb study results of BTI-320 in patients with type 2 diabetes and more... |
| 2014-10-09 00:15 | | Levicept emerges from Pfizer's R&D ashes with $20M and a new pain drug and more... |
| 2014-10-08 12:15 | | Arrowhead Sinks on Disappointing Hepatitis B Drug Data and more... |
| 2014-10-08 00:15 | | [video]Actavis plans new Allergan approach: Report and more... |
| 2014-10-07 12:15 | | Bristol-Myers Squibb pulls FDA filing for asunaprevir, citing rapidly evolving hepatitis C field and more... |
| 2014-10-07 00:15 | | Number of companies fighting Ebola grows, one wins fed OK and more... |
| 2014-10-06 12:15 | | Vivus announces journal publication of Qsymia study results in type 2 diabetes and more... |
| 2014-10-05 12:15 | | The Stunning Mobile Game Changer for Diabetics That Investors Can't Ignore and more... |
| 2014-10-04 12:15 | | 'Isis' name association a plague for businesses and more... |
| 2014-10-04 00:15 | | Genentech Sales Reps Face Hospital Bans Over a Wholesale Change and more... |
| 2014-10-03 12:15 | | Top 10 pharma companies by number of employees - 2014 and more... |
| 2014-10-03 00:15 | | Takeda Accused of Putting Actos Profit Ahead of Safety and more... |
| 2014-10-02 12:15 | | The Gators are Snapping as Hospira Gets Another FDA Warning Letter and more... |
| 2014-10-02 00:15 | | Sales rep restrictions point to need for a pharma rethink and more... |
| 2014-10-01 12:15 | | Zogenix Submits Modified Formulation of Zohydro(R) ER With Potential Abuse Deterrent Properties for FDA Review and more... |
| 2014-10-01 00:15 | | Melanoma Treatment Battle Between Roche And GSK Heats Up and more... |
